Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification

  1. San Miguel, J.F.
  2. Vidriales, M.B.
  3. López-Berges, C.
  4. Díaz-Mediavilla, J.
  5. Gutiérrez, N.
  6. Cañizo, C.
  7. Ramos, F.
  8. Pérez, J.J.
  9. González, M.
  10. Orfao, A.
Revista:
Blood

ISSN: 0006-4971

Ano de publicación: 2001

Volume: 98

Número: 6

Páxinas: 1746-1751

Tipo: Artigo

DOI: 10.1182/BLOOD.V98.6.1746 GOOGLE SCHOLAR lock_openAcceso aberto editor